The Cooper Companies, Inc. (NYSE: COO), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry, primarily focusing on contact lenses and women’s health. With a market capitalization of $16.71 billion, this U.S.-based company has been a notable player since its inception in 1958, headquartered in San Ramon, California.

Currently trading at $84.07, the stock’s performance over the past year has seen it range between $64.32 and $91.65. While the company’s P/E ratio remains undisclosed, its forward P/E stands at a promising 16.97, hinting at expected earnings growth and a potentially attractive valuation for future investors. The absence of a PEG ratio and other valuation metrics like…